Wikipedia:Version 1.0 Editorial Team/Chemicals articles by quality log

October 3, 2024

Reassessed

• Cosyntropin (talk) reassessed. Importance rating changed from Mid-Class to NA-Class. (rev · t)
• Dyflos (talk) reassessed. Importance rating changed from Low-Class to NA-Class. (rev · t)
• O,O′-Diacetyldopamine (talk) reassessed. Quality rating changed from NA-Class to C-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
• Thyroxine (talk) reassessed. Importance rating changed from NA-Class to Mid-Class. (rev · t)
• Triethylene glycol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

• 2,4-Dichloroamphetamine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• 2′-CH3-MPTP (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• 2′-NH2-MPTP (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• 3-Chloroamphetamine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

October 2, 2024

Reassessed

• 3,4-Dihydroxymethamphetamine (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)
• Chlorhexidine gluconate (talk) reassessed. Importance rating changed from Mid-Class to NA-Class. (rev · t)
• DA-Phen (talk) reassessed. Quality rating changed from NA-Class to Start-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
• Dimer (talk) reassessed. Importance rating changed from NA-Class to Low-Class. (rev · t)
• Glycerine acetate (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Gold fluoride (talk) reassessed. Quality rating changed from NA-Class to List-Class. (rev · t)
• O,O′-Dipivaloyldopamine (talk) reassessed. Quality rating changed from NA-Class to Start-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
• Semorinemab (talk) reassessed. Quality rating changed from NA-Class to Stub-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
• Tetramminecopper(II) sulfate (talk) reassessed. Importance rating changed from Low-Class to NA-Class. (rev · t)

Assessed

• Draft:3-Acetylpyridine draft 1 (talk) assessed. Importance assessed as NA-Class. (rev · t)
• BMS-202 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Trans-2-Hexenal (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

October 1, 2024

Reassessed

• Darodipine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Deoxycytidine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Dimer (talk) reassessed. Importance rating changed from Low-Class to NA-Class. (rev · t)
• Dissociation rate (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Dynorphin B (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Nitrofen (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Phenatine (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)
• Premarin (talk) reassessed. Importance rating changed from Low-Class to NA-Class. (rev · t)
• Sinapaldehyde (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

• 3,4-Dihydroxymethamphetamine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• DA-Phen (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• N-Acetyl-γ-aminobutyraldehyde (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• N-Acetyl-γ-aminobutyric acid (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• N-Acetylputrescine (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• O,O′-Diacetyldopamine (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• O,O′-Dipivaloyldopamine (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• ODMA (drug) (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Oxitriptan (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
• SeDMA (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Semorinemab (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• TDMA (drug) (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

Removed

• Category:3-(4-methoxyphenyl)-2-oxazolidinones (talk) removed.

September 30, 2024

Reassessed

• Bisorcic (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)
• PF-04455242 (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)
• PrP (talk) reassessed. Quality rating changed from Disambig-Class to NA-Class. (rev · t)
• Prodipine (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)
• Thyroxine (talk) reassessed. Importance rating changed from Mid-Class to NA-Class. (rev · t)

Assessed

• Phenatine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Tetrakis(1-norbornyl)cobalt(IV) (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

Removed

• Draft:Nouryon (talk) removed.

September 29, 2024

Reassessed

• Anti-α-synuclein drug (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)

Assessed

• 6-Hydroxydopa (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Actinoid contraction (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Bisorcic (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• PF-04455242 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Prodipine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

September 28, 2024

Renamed

• Anti-α-synuclein drug renamed to Anti-α-synuclein drug.
• Draft:Cinpanemab renamed to Cinpanemab.

Reassessed

• Iodine nitrate (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Levetiracetam (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
• Quillaia (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

• Centpropazine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Flerobuterol (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• Glances (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Melevodopa/carbidopa (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Phenylpiracetam (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Pirepemat (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• Wakefulness-promoting agent (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• XP-21279 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

September 27, 2024

Renamed

• Beta-lactam renamed to Β-Lactam.
• Betahydroxyfentanyl renamed to Β-Hydroxyfentanyl.
• Betahydroxythiofentanyl renamed to Β-Hydroxythiofentanyl.
• GSK-598809 renamed to GSK-598809.
• Hexyl cinnamaldehyde renamed to Α-Hexylcinnamaldehyde.

Reassessed

• 4-Benzylpiperidine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Ervaticine (talk) reassessed. Quality rating changed from Stub-Class to NA-Class. (rev · t)

Assessed

• AG2037 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Aleniglipron (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Ampreloxetine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Draft:Anti-α-synuclein drug (talk) assessed. Importance assessed as NA-Class. (rev · t)
• Armesocarb (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• BAY 12-9566 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Benzoylphenylurea (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Draft:Cinpanemab (talk) assessed. Importance assessed as NA-Class. (rev · t)
• Mesdopetam (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• OMT-28 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Prasinezumab (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• RGPU-95 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Tert-Butyl methacrylate (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
• Α-Hexylcinnamaldehyde (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Β-Hydroxyfentanyl (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Β-Hydroxythiofentanyl (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Β-Lactam (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Low-Class. (rev · t)